Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


22.11.2021

1 Acta Neurol Scand
1 BMC Neurol
1 Eur Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
1 J Neurosci Res
4 Mult Scler
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. CHAABAN L, Safwan N, Moussa H, El-Sammak S, et al
    Central vein sign: A putative diagnostic marker for multiple sclerosis.
    Acta Neurol Scand. 2021 Nov 18. doi: 10.1111/ane.13553.
    PubMed         Abstract available


    BMC Neurol

  2. SHARIFI MH, Keshani P, Salehi A, Jaladat AM, et al
    Association between multiple sclerosis and dietary patterns based on the traditional concept of food nature: a case-control study in Iran.
    BMC Neurol. 2021;21:453.
    PubMed         Abstract available


    Eur Neurol

  3. BARREIRO-GONZALEZ A, Sanz MT, Carratala-Bosca S, Perez-Miralles F, et al
    Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.
    Eur Neurol. 2021 Nov 17:1-10. doi: 10.1159/000519772.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  4. NIJ BIJVANK J, Uitdehaag BMJ, Petzold A
    Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics.
    J Neurol Neurosurg Psychiatry. 2021 Nov 11. pii: jnnp-2021-327468.
    PubMed         Abstract available


    J Neurol Sci

  5. KENNEY R, Liu M, Patil S, Alroughani R, et al
    Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry.
    J Neurol Sci. 2021;430:118067.
    PubMed         Abstract available


    J Neurosci Res

  6. KOUBIYR I, Dulau-Metras C, Deloire M, Charre-Morin J, et al
    Amygdala network reorganization mediates the theory of mind performances in multiple sclerosis.
    J Neurosci Res. 2021 Nov 19. doi: 10.1002/jnr.24986.
    PubMed         Abstract available


    Mult Scler

  7. MAUBEUGE N, Deloire MS, Brochet B, Charre-Morin J, et al
    Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.
    Mult Scler. 2021 Nov 12:13524585211054006. doi: 10.1177/13524585211054006.
    PubMed         Abstract available

  8. MARRIE RA, McKay K
    Administrative data for observational research in multiple sclerosis: Opportunities and challenges.
    Mult Scler. 2021 Nov 17:13524585211055787. doi: 10.1177/13524585211055787.
    PubMed        

  9. SCHORR EM, Kurz D, Rossi KC, Zhang M, et al
    Depression readmission risk is elevated in multiple sclerosis compared to other chronic illnesses.
    Mult Scler. 2021 Nov 17:13524585211051316. doi: 10.1177/13524585211051316.
    PubMed         Abstract available

  10. KIRA JI, Nakahara J, Sazonov DV, Kurosawa T, et al
    Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
    Mult Scler. 2021 Nov 17:13524585211055934. doi: 10.1177/13524585211055934.
    PubMed         Abstract available


    PLoS One

  11. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    PubMed         Abstract available

  12. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: